VRUS: To Present At Lazard Capital Healthcare Conference @ 08:55 ET [delayed] -
VRUS: To Present At Rodman & Renshaw Investment Conference @ 12:25 ET [delayed] -
Pharmasset to Present at Two Upcoming Investor Conferences -
Pharmasset to Webcast an Investor Event from the AASLD Meeting -
Pharmasset, Inc. (VRUS) Corporate Event Announcement Notice -
Pharmasset to Present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th -
VRUS: To Present At JMP Securities Healthcare Conference @ 10:00 ET [delayed] -
Pharmasset to Present at the JMP Securities Healthcare Focus Conference on Monday, October 6th -
VRUS: To Present At UBS Global Life Sciences Conference @ 16:00 ET [delayed] -
VRUS: Positive Preliminary Results from Ph 1 Trial of R7128 for Hepatitis C -
Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 -
VRUS: To Present At Canaccord Adams Global Growth Conference @ 11:30 ET [delayed] -
Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th -
VRUS: Announces Preliminary Results of Third Cohort in Ph I Trial of R7128 -
Pharmasset Joins Russell 3000 Index -
Pharmasset Receives Notice of Allowance -
Zelos Therapeutics Appoints Alan S. Roemer as Chief Financial Officer -